文献速递其他结缔组织病

早发型原发性干燥综合征的临床特征与循环淋巴细胞谱

Patients with early-onset primary Sjögren's syndrome have distinctive clinical manifestations and circulating lymphocyte profiles.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该回顾性研究分析了333例原发性干燥综合征(pSS)患者,比较35岁及以下诊断的早发型与晚发型患者的临床、实验室及外周血淋巴细胞亚群特征。早发型患者占10.81%,其血清IgG升高、补体降低、抗SSA/SSB阳性率及血液、肾脏、皮肤黏膜受累频率均更高,ESSDAI评分更高,并存在显著CD4+ T细胞减少。结论提示早发型pSS临床表现更重、免疫激活更明显,需更积极治疗和密切随访。

要点

  • 早发型pSS(≤35岁诊断)占10.81%,血清IgG升高、低补体及抗SSA/SSB阳性更常见。
  • 早发型pSS血液、肾脏、皮肤黏膜受累频率及ESSDAI评分显著高于晚发型。
  • 早发型pSS存在显著CD4+ T细胞减少,提示细胞免疫系统过度激活。

核心结论

  • 早发型pSS患者具有独特的临床表现和更活跃的细胞免疫系统,症状及免疫学特征更重,预后不良。

研究设计与样本

  • 回顾性分析333例pSS患者,以35岁及以下诊断为早发型,比较早发型与晚发型患者的临床、实验室及外周血淋巴细胞亚群免疫表型。

主要发现

  • 早发型pSS患者血清IgG升高比例77.14% vs 31.16%(P<0.001),低C3比例41.67% vs 20.20%(P=0.004),低C4比例27.78% vs 6.40%(P<0.001)。
  • 早发型pSS患者抗SSA阳性率91.67% vs 51.85%(P<0.001),抗SSB阳性率50% vs 20.54%(P<0.001)。
  • 早发型pSS患者血液系统受累80.56% vs 52.53%(P=0.001),肾脏受累19.44% vs 5.05%(P=0.005),皮肤黏膜受累50% vs 22.56%(P<0.001)。
  • 早发型pSS患者ESSDAI评分为11(6.25-17) vs 7(3-12),P=0.003。
  • 早发型pSS患者存在显著CD4+ T细胞减少。

关键数值与推荐

  • 早发型定义为pSS诊断年龄≤35岁。

临床怎么用

  • 对早发型pSS患者应考虑更积极的糖皮质激素和/或免疫抑制剂治疗,并加强随访和定期监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To further investigate the clinical characteristics and circulating lymphocyte profiles of patients with early-onset primary Sjögren's syndrome (pSS). METHOD: Data of 333 patients with pSS were analysed retrospectively. Early onset was defined as a pSS diagnosis at an age of 35 years or younger. The clinical, laboratory and immunophenotypic profiles of peripheral blood lymphocyte subsets were compared between early- and later-onset pSS. RESULTS: Thirty-six (10.81%) patients matched the definition of early-onset pSS, with age at disease onset being 28.97 (5.53) years. Elevated serum IgG level (77.14% vs 31.16%, P <0.001), low C3 (41.67% vs 20.20%, P =0.004) and C4 levels (27.78% vs 6.40%, P <0.001), anti-SSA positivity (91.67% vs 51.85%, P <0.001) and anti-SSB positivity (50% vs 20.54%, P <0.001) were more frequent in early-onset patients. The frequencies of hematological (80.56% vs 52.53%, P =0.001), renal (19.44% vs 5.05%, P =0.005) and mucocutaneous involvement (50% vs 22.56%, P <0.001) were significantly higher in the early-onset pSS group, which showed a higher 2010 EULAR SS Disease Activity Index (ESSDAI) [11(6.25-17) vs 7(3-12); P =0.003], compared with the later-onset group. In addition, profound CD4+ T-cell lymphopenia was found in patients with early-onset. CONCLUSIONS: Patients with early-onset pSS have distinctive clinical manifestations and greater activation of the cellular immune system, present with more severe clinical symptoms and immunological features, have increased activation of circulating T cells and have an unfavourable prognosis. Thus, they require more positive treatment with glucocorticoids and/or immunosuppressants and merit closer follow-up and regular monitoring.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wei L, Zhifei X, Xiaoran N, et al. Patients with early-onset primary Sjögren's syndrome have distinctive clinical manifestations and circulating lymphocyte profiles. Rheumatology (Oxford). 2022. PMID: 33878180. doi:10.1093/rheumatology/keab367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。